Literature DB >> 34384527

Early Human Postnatal Brain Development Through the Lens of Rare Genetic Disorders.

Eric M Morrow1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34384527      PMCID： PMC8767462          DOI： 10.1016/j.biopsych.2021.07.001

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   12.810


× No keyword cloud information.
  9 in total

Review 1.  Genetic control of postnatal human brain growth.

Authors:  Laura I van Dyck; Eric M Morrow
Journal:  Curr Opin Neurol       Date:  2017-02       Impact factor: 5.710

2.  DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.

Authors:  Jianling Ji; Hane Lee; Bob Argiropoulos; Naghmeh Dorrani; John Mann; Julian A Martinez-Agosto; Natalia Gomez-Ospina; Natalie Gallant; Jonathan A Bernstein; Louanne Hudgins; Leah Slattery; Bertrand Isidor; Cédric Le Caignec; Albert David; Ewa Obersztyn; Barbara Wiśniowiecka-Kowalnik; Michelle Fox; Joshua L Deignan; Eric Vilain; Emily Hendricks; Margaret Horton Harr; Sarah E Noon; Jessi R Jackson; Alisha Wilkens; Ghayda Mirzaa; Noriko Salamon; Jeff Abramson; Elaine H Zackai; Ian Krantz; A Micheil Innes; Stanley F Nelson; Wayne W Grody; Fabiola Quintero-Rivera
Journal:  Eur J Hum Genet       Date:  2015-05-06       Impact factor: 4.246

3.  Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage.

Authors:  Jessica A Gorski; Tiffany Talley; Mengsheng Qiu; Luis Puelles; John L R Rubenstein; Kevin R Jones
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

4.  Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.

Authors:  Vassiliki Fotaki; Mara Dierssen; Soledad Alcántara; Salvador Martínez; Eulàlia Martí; Caty Casas; Joana Visa; Eduardo Soriano; Xavier Estivill; Maria L Arbonés
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 5.  Current Approaches and Future Directions for the Treatment of mTORopathies.

Authors:  Vasiliki Karalis; Helen S Bateup
Journal:  Dev Neurosci       Date:  2021-04-28       Impact factor: 2.984

Review 6.  The basics of brain development.

Authors:  Joan Stiles; Terry L Jernigan
Journal:  Neuropsychol Rev       Date:  2010-11-03       Impact factor: 7.444

7.  Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling.

Authors:  Jenna A Levy; Christy W LaFlamme; George Tsaprailis; Gogce Crynen; Damon T Page
Journal:  Biol Psychiatry       Date:  2021-04-08       Impact factor: 12.810

8.  A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome.

Authors:  Alexander Kolevzon; Lauren Bush; A Ting Wang; Danielle Halpern; Yitzchak Frank; David Grodberg; Robert Rapaport; Teresa Tavassoli; William Chaplin; Latha Soorya; Joseph D Buxbaum
Journal:  Mol Autism       Date:  2014-12-12       Impact factor: 7.509

9.  Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome.

Authors:  Heather M O'Leary; Walter E Kaufmann; Katherine V Barnes; Kshitiz Rakesh; Kush Kapur; Daniel C Tarquinio; Nicole G Cantwell; Katherine J Roche; Suzanne A Rose; Alexandra C Walco; Natalie M Bruck; Grace A Bazin; Ingrid A Holm; Mark E Alexander; Lindsay C Swanson; Lauren M Baczewski; Chi‐Sang Poon; Juan M Mayor Torres; Charles A Nelson; Mustafa Sahin
Journal:  Ann Clin Transl Neurol       Date:  2018-01-31       Impact factor: 4.511
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.